Fierce Biotech News & Reports
3 days ago · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and …
FDA lifts hold on Iovance's lung cancer cell therapy trial - Fierce …
Mar 4, 2024 · Iovance Biotherapeutics ended 2023 on a downer courtesy of a partial clinical hold from the FDA, but the situation has been resolved relatively quickly.. The agency implemented …
After a tough year, Exscientia folds into Recursion - Fierce Biotech
Aug 8, 2024 · But, in 2022, Bayer parted ways on a 240 million euro ($243 million) partnership. And, despite adding a collaboration with Merck KGaA in September 2023 that could top $1 …
3 years after rejecting $1B buyout, Sorrento files for bankruptcy …
Feb 13, 2023 · Sorrento contends that Soon-Shiong originally suggested that Celgene buy the generic rival, called Cynviloq, but that the larger pharma rejected the proposal on the grounds …
Novartis entrenches into radiopharma with $1B Mariana buy
May 2, 2024 · Novartis was specifically interested in Mariana’s focus on the radioactive metallic element actinium, whereas the Swiss pharma’s other approved radioligand therapies use …
Ono inks $700M biobuck deal to bag preclinical LigaChem ADC
Oct 10, 2024 · Ono Pharmaceutical has bought a seat in a quiet corner of the congested antibody-drug conjugate (ADC) space, agreeing to pay LigaChem Biosciences up to $700 …
Genentech inks $850M upfront deal for Regor's CDK inhibitors
Sep 30, 2024 · Genentech is paying $850 million upfront for Regor Pharmaceuticals’ portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single …
Upstream swells IPO to $255M as it lists alongside CAMP4
Oct 11, 2024 · Upstream Bio has swollen its IPO up to $255 million as the company joins CAMP4 this morning in becoming the latest biotechs to list on the Nasdaq.
FDA approves Novocure’s tumor field therapy for metastatic NSCLC
Oct 16, 2024 · Novocure submitted Optune Lua for FDA review in NSCLC in December 2023, after also seeking a CE Mark approval in Europe. Around the same time—and following the …
FDA clears first non-drug fibromyalgia treatment - Fierce Biotech
May 19, 2022 · The Quell device received an initial 510(k) clearance from the FDA in 2014, when it was indicated as an over-the-counter treatment for chronic pain—without a specific focus on …